Background. Australians living in rural regions have poorer health outcomes than city residents. This study compares rural and city patient access to and outcomes of renal replacement therapy (RRT) in Australia. Methods. Non-indigenous Australians aged !16 years who commenced dialysis or underwent renal transplantation between 1996 and 2009 and were registered with the Australia and New Zealand Dialysis and Transplant Registry were included. Each patient's location was classified according to a remote area index as major city (MC), inner regional (IR), outer regional (OR) or remote/very remote (REM 
Introduction
People living in rural areas of Australia have poorer health outcomes than those living in cities. Mortality rates in regional areas are higher than major cities (MCs) and increase further with increasing remoteness [1] . This variation remains after correcting for the greater indigenous population in remote Australia. Possible explanations include access to health services, physical inactivity, excess alcohol, poor nutrition, unemployment and lower socioeconomic status. Rural residence has been associated with increased mortality rates for cancer [2, 3] , circulatory disease, chronic obstructive pulmonary disease and trauma [1] . Furthermore, rural residents undergo fewer diagnostic [4] [5] [6] or therapeutic interventions [7, 8] than Australians in MCs.
There are few studies examining rates of end-stage kidney disease (ESKD) in rural areas. United States data reports rural dialysis patients are older, less racially diverse, have more comorbidities and undertake peritoneal dialysis more frequently than city patients. In a multivariable model, dialysis patient survival in rural areas compared to cities was better for non-Hispanic white and black patients but worse for Hispanic patients [9] . Mortality among peritoneal dialysis patients in Canada has been shown higher in rural locations than cities [10] . The impact of rural residence in the USA on transplantation is mixed, with one study reporting lower waiting list registration and transplant rates in rural areas [11] but another study reporting similar or greater likelihood of renal transplantation when living further away from a transplant centre [12] .
The specialist field and nature of the technology involved to deliver renal replacement therapy (RRT) would suggest that rural people with ESKD may be at risk of less access to and poorer outcomes from RRT than city patients. The aim of this study was to compare RRT incidence and prevalence rates and dialysis and transplant patient characteristics and survival in rural and city locations in Australia.
Materials and methods
The Australia and New Zealand Dialysis and Transplant Registry (ANZ-DATA) collects observational data on all patients receiving RRT in Australia and New Zealand, including postcode at entry to the programme. All data are collected and submitted to ANZDATA by the treating nephrologist or renal health team at each local site. This study included all non-indigenous patients aged !16 years registered with ANZDATA who commenced dialysis or received a transplant in Australia between 1 January 1996 and 31 December 2009. Indigenous patients (those who self identify when asked their racial origin) were excluded from this analysis because work in this area has been completed previously [13] .
The Australian Bureau of Statistics used 2001 Census data to produce the Australian Standard Geographical Classification of remoteness areas. This classifies all statistical local areas according to a remote area index. The remote area index is determined by measuring the road distance from a statistical local area to five classes of service centre. There are six remote area index classifications: MC, inner regional (IR), outer regional (OR), remote, very remote and migratory [14] . Urban areas include the MC category, while rural areas include regional, remote and very remote Australia (Figure 1 ). In Australia, travel from rural areas to the nearest renal service may be many hundreds of kilometres. We allocated a remote area index category to every Australian postcode using the statistical local area data. Where a postcode contained statistical local areas from two or more remote area index classifications, the postcode was allocated the remote area index that had the greatest population. New Zealand and international patients do not have postcode data and were excluded from the analysis. Australian patients without postcode data recorded at commencement of RRT were excluded. Patient numbers in the remote and very remote areas were small so these groups were combined into a single remote (REM) category. . These population estimates were used to directly standardize RRT incidence and prevalence rates by remote area index for age and gender. Poisson regression was used to compare incidence and prevalence rates while adjusting for age and gender.
Baseline characteristics at commencement of dialysis or at time of transplant were compared between remote area index categories using the chi-square test for categorical data and Kruskall-Wallis test for continuous non-normally distributed data.
Survival analyses were performed using multivariable Cox proportional hazards models. For patient survival on dialysis, covariates included in the model were age, gender, racial origin, body mass index, primary renal disease, peripheral vascular disease, cerebrovascular disease, ischaemic heart disease, chronic lung disease, diabetes, smoking status (never/ former or current), late referral (<3 months before commencing dialysis) to a nephrologist, dialysis modality and state. Models for graft and patient survival of transplant recipients included age, gender, race, body mass index, primary renal disease, smoking status, peripheral vascular disease, cerebrovascular disease, ischaemic heart disease, chronic lung disease, diabetes, duration of dialysis prior to transplant, donor source by total ischaemia time (living donor, deceased donor <12 h, deceased donor 12-18 h, deceased donor !18 h or deceased donor unknown ischaemia time), peak panel reactive antibody, number of human leucocyte antigen (HLA) mismatches and state.
Data were censored for renal transplantation (dialysis patients only), recovery of renal function, loss to follow-up and end of study (31 December 2009). Proportional hazards assumptions were checked by Schoenfeld residuals and scaled Schoenfeld residuals, examined by formal hypothesis test and graphically. Data were analysed using Stata/IC 11 (College Station, TX). P-values <0.05 were considered statistically significant.
Results

Baseline characteristics
A total of 24 068 people commenced dialysis during the study period; patient characteristics at commencement of dialysis by remote area index are shown in Table 1 . There were significant differences between city and rural patients. MC patients were least likely to be current smokers, referred to a nephrologist <3 months from commencement of dialysis or be treated with peritoneal dialysis as initial modality. MC patients were most racially diverse with the lowest prevalence of Caucasians and the highest prevalence of Asian race. Diabetes was less common among the rural categories. Dialysis patient primary renal disease by remote area index is shown in Table 2 ; although rates of glomerulonephritis, hypertension and diabetic nephropathy did vary between remoteness groups, there was no consistent gradation.
A total of 5399 underwent renal transplantation during the study period. Transplant patient characteristics by remote area index are shown in Table 3 . There were fewer differences between city and rural patients in this group than the dialysis group. There were no differences in age, co-morbidities, dialysis duration prior to transplantation, living donor rates, pre-emptive transplantation, peak panel reactive antibody or HLA mismatches. As expected, total ischaemic time for rural patients receiving deceased donor kidneys was longer.
Incidence and prevalence Figure 2 shows the standardized incidence rates adjusted for age and gender for all patients commencing RRT by remote area index, with higher incidence rates in MCs than all rural areas. Figure 3A and B shows the standardized prevalence rates adjusted for age and gender for dialysis and transplant patients, respectively. Compared with MC, prevalence rates for dialysis were lower in OR and REM areas. In contrast, prevalence rates for transplant patients were higher in IR and OR areas compared with MC.
Patient outcomes
There were 10 739 dialysis patient deaths during the study period. Table 4 shows that compared with the MC group, dialysis patient survival in IR and OR areas was worse. There was considerable variation in the remoteness effect between different states. OR and REM dialysis patients were more likely to have a cardiac death and less likely to withdraw from dialysis (Table 5 ). There was no difference by remote area index for reason for withdrawing from dialysis (P ¼ 0.62). Table 6 shows the transplant patient outcomes by remote area index. MC patients were least likely to have acute rejection in the first 6 months post-transplantation. There was no difference in delayed graft function needing dialysis or creatinine >200 lmol/L at 6 months by remote area index. Patient and graft survival were similar in MC, IR and REM groups. Compared with MC, graft survival was worse in OR and there was a trend to worse patient survival. For transplant patients, there was no difference between cause of death (P ¼ 0.75) or graft failure (P ¼ 0.38) by remote area index.
Discussion
This study has shown that the incidence of RRT in rural areas of Australia is lower than in MCs. The prevalence of dialysis is lower in OR and REM areas, but transplant prevalence is higher in IR and OR Australia. Commencing dialysis in IR or OR Australia is an independent predictor of mortality. Except for poorer graft survival in OR areas, transplant patient outcomes are not affected by geographical location.
There are several possible explanations for the lower incidence of RRT in rural areas. ANZDATA records postcode information at the time of commencement of RRT. Dialysis, in particular, may not be available in a rural location and as a result some rural patients approaching treatment may relocate to cities prior to starting RRT. These patients will then be recorded under the MC category. While there is anecdotal evidence that the ill and elderly may migrate to urban areas, there is little published data [1] .
The incidence data may suggest that ESKD is less common in rural Australia. This seems highly unlikely. Like other renal registries, ANZDATA only records patients who commence RRT. There is no record of patients with ESKD who are managed with a non-dialysis (palliative) pathway. It is plausible that patients in rural areas may choose palliation rather than dialysis more frequently than those in cities. Possible reasons to choose palliation may include the burden of travel to dialysis or specialist care, non-referral to specialist care and poor education about RRT options. Canadian data show that local access to treatment is important and building satellite haemodialysis units in rural areas results in a significant increase in the number of elderly receiving RRT [15] . A major barrier to medical care, including RRT in rural Australia, is distance and travel. In our study, the rate of peritoneal dialysis was higher in rural regions, reflecting both the benefits of home therapies in this group and likely poor access to satellite haemodialysis units. An increased rate of peritoneal dialysis in rural regions of the USA has also been shown despite rural facilities being less likely to offer peritoneal dialysis training [9] . While peritoneal dialysis rates were higher among rural patients in our study, haemodialysis remained numerically the main treatment modality. One option to reduce travel is home haemodialysis, but there may be barriers to this modality in rural Australia that are not encountered in cities, particularly water quantity and quality. In the USA, rural facilities were less likely to offer home haemodialysis training [9] and had lower rates of home dialysis (peritoneal and home haemodialysis combined) among rural compared with city patients [16] . Our study did not examine where training for peritoneal dialysis or home haemodialysis occurs, but it is likely that many rural patients may need to live away from home for some period to complete training. This may be a significant disincentive to undertake home dialysis therapies and if a haemodialysis facility is not located nearby, patients may chose a palliative pathway. If home dialysis is not an option for a patient, they must travel (or relocate) to the nearest facility for maintenance haemodialysis. Travel can add several hours to the treatment and result in dialysis taking all day. Transport to and from dialysis is a problem if the patient cannot drive; across Australia, approaches to government support of travel costs vary widely. A study of regional Australian patients needing to travel to a city for radiotherapy treatment identified concerns with the burden of travel, difficulties in living away from home, financial concerns, distance from family and friends and feelings of being a burden on others [17] . Data from the Dialysis Outcomes and Practice Patterns Study found longer travel time to dialysis was associated with a greater mortality risk and decreased health-related quality of life. Interestingly, this was not because patients with further to travel decided to withdraw from treatment [18] , results confirmed by our study. In summary, distance is a marker for both a lower incidence of treatment for ESKD and reduced survival after commencing dialysis in rural regions.
Access to health care providers is a significant problem for rural patients. The Australian Institute of Health and Welfare studied the medical workforce in 2003 [19] . After correcting for clinical care performed outside the primary practice location, the number of full-time equivalent medical staff per 100 000 population by remote area index was 316 MC, 181 IR, 161 OR, 166 remote and 157 very remote. In 2007, a survey of the Australian nephrology workforce was completed [20] . Eighty-eight per cent of respondents reported their primary site of practice was an MC, with only 9% IR, 2% OR and 0.4% REM. Furthermore, many nephrologists reported other sites of practice, but for those with a primary site in an MC, their other sites were also usually within an MC. Thus, Australian data suggest people with kidney disease in rural regions have less access to a nephrologist unless they travel to an MC. Canadian data have shown that people with kidney disease who live >50 km from a nephrologist have poorer outcomes than those who live <50 km away. Canadian patients with chronic kidney disease not on dialysis living >50 km from the nearest nephrologist, when compared with patients living <50 km from the nearest nephrologist, are less likely to receive specialist care, recommended laboratory testing and appropriate medications. They were also more likely to die or be hospitalized [21] . Similarly, Canadian studies examining the impact of distance between the home of a dialysis patient and practice of the treating nephrologist have found that a distance of >50 km was associated with an increased risk of death for haemodialysis [22] and peritoneal dialysis [10] patients compared with distances of <50 km.
There may be other factors that may contribute to the poorer dialysis survival we found in IR and OR Australia. For example, we did not compare key performance indicators such as dialysis adequacy, dialysis hours, vascular access at first dialysis, haematology or biochemistry between city and rural groups. However, in the USA, similar haematocrit targets were achieved and rural units achieved target urea reduction ratios more frequently than city units [9] . Patient compliance may be different between rural and city patients with regard to medications and possibly dialysis hours. Patients often request a reduction in dialysis hours, and this may be more common among patients who already have significant travel time for each dialysis session. There may be difficulties attracting and retaining qualified and skilled staff in rural areas. Rural areas may have problems with ongoing education of health professionals, maintenance of equipment or patient travel for vascular access. Our data showed transplant prevalence in IR and OR Australia was higher than in MC. This is consistent with previously published data showing an increased likelihood of transplantation in rural areas [12] . Transplantation is the best management option for most patients with ESKD, but particularly rural patients as it resolves the problems of regular travel for dialysis. Pleasingly, transplant patient and graft survival were comparable to MC for all groups except graft survival in OR areas. Possible reasons for these similar outcomes include the patient being under the care of a transplant nephrologist or transplant centre with standardized care or that transplantation is less affected by distance than dialysis.
There are a number of options to reduce the gap between rural and city RRT incidence and dialysis outcomes. Developing satellite haemodialysis units in rural areas has been shown to increase access for elderly patients and reduce travel time and distance [14] . This may reduce the gap in incident RRT rates between OR and REM areas and the city. Other ways to reduce travel time such as dedicated transport services that minimize the idle time between arriving at the dialysis unit and commencing dialysis and finishing dialysis and leaving the unit may assist. Efforts to increase the medical workforce have been ongoing [23] and full-time equivalent staff numbers have increased [24] , but it remains to be seen if this will improve the health of rural Australians. Whether improving nephrology outreach clinic services or permanent placement of a nephrologist in a rural area improves access and outcomes is not proven but seems highly likely to be beneficial. Provision of training for both peritoneal dialysis and home haemodialysis in rural areas and encouraging patient uptake of these home therapies may improve access to RRT. Telehealth is being used to improve rural patient outcomes and access to specialist care [25, 26] . Efforts to educate rural primary health care providers may improve referral rates and appropriate care of chronic kidney disease patients. Education and behaviour change among rural residents, such as stopping smoking, may also assist.
Our study has several limitations. Firstly, postcode data at entry to RRT were used in this study. We do not know how many or how often patients relocate to access health care for kidney disease prior to commencing RRT. Relocation after commencing RRT was low. ANZDATA has collected current postcode data since 2005 and only 0.3% of patients moved from one remote area index classification to another, with movement equal in both directions. Secondly, patients who commenced RRT in Australia but did not have a postcode recorded were excluded. This would not have affected our analysis as only 0.04% (n ¼ 10) had no postcode data recorded at entry. Thirdly, the method used to classify a postcode by remote area index relied on data from statistical local areas and some postcodes had several different remote area index classifications of statistical local areas. Our classification of each postcode may thus have created a bias, although we used the most populous remote area index allocation for each postcode. Fourthly, we have no data on patients who were managed conservatively and never commenced RRT. Finally, the data are observational and there are confounding variables that may contribute to our understanding. Rural residence and distance to treatment are not the cause for poor outcomes but mark for other factors which are.
In conclusion, our findings show Australians living in rural areas compared with cities have poor access to RRT and many have worse outcomes on dialysis. We recommend that efforts be made to improve access to nephrology care through primary care practitioners, specialists, nursing and allied health staff and dialysis at the local level to reduce travel and the burden of a chronic disease in rural areas. Any changes to service provision should be used as an opportunity to study the effects on rural patient health. 
